Depo-Provera Emulgel is indicated in women who are pregnant or may be may be puerperating or may be undergoing pregnancy and in women aged 12 years and older.
Hypersensitivity to medroxyprogesterone acetate or to other progestogens.
Animal studies show that pregnancy is not associated with any adverse effects from the use of progestogens.
The following adverse effects have been identified with the use of Depo-Provera Emulgel, please talk to your doctor:
The use of Depo-Provera Emulgel may increase the risk of drinking or taking other medicines containing alcohol while using the medicine.
The use of Depo-Provera Emulgel is not recommended for use in the elderly. The risk of lagedolge (a medication for erectile dysfunction) and other serious side effects may be increased.
No reports of adverse events have been published in pediatric age with the use of Depo-Provera Emulgel. The safety of Depo-Provera Emulgel in children under 12 years of age has not been studied.
Dr. Opin can help develop a personalized treatment plan based on the specific circumstances of each patient and the doctor who is working with them.
The following have been identified by the doctor based on the use of Depo-Provera Emulgel:
Generalised breast lumps and breast enlargement have been reported with the use of Depo-Provera Emulgel.
Mood changes and depression have been reported with the use of Depo-Provera Emulgel.
The use of Depo-Provera Emulgel may increase the risk of having an irregular or new vaginal bleeding.
The use of Depo-Provera Emulgel may increase the risk of having an abnormal ejaculation (difficulty in achieving or maintaining an erection).
Breast lumps or pain at the injection site have been reported with the use of Depo-Provera Emulgel.
The use of Depo-Provera Emulgel may increase the risk of having an abnormal hormone (like testosterone) (like oestrogen or progestogen) level (like oestrogen and progestogen) level.
Breast milk is a breast-federvative, and is therefore not recommended for the use of medroxyprogesterone acetate.
The use of hormonal contraception may cause a significant reduction in bone mineral density, according to a new published in the Journal of the American Academy of Child and Adolescent Psychiatry.
The American Society for Sexual Medicine has recommended that a woman taking Provera (a synthetic form of the hormone progesterone) should be able to resume her menstrual cycle in order to reduce the risk of osteoporosis (thinning of bones) and bone loss.
The American Journal of Obstetricians and Gynecologists (AGB) has also suggested that a woman taking Depo-Provera (a synthetic form of the hormone progesterone) should be able to resume her menstrual cycle in order to reduce the risk of osteoporosis (thinning of bones) and bone loss.
“Provera is an effective medication for women who suffer from hormonal birth control that works by preventing the breakdown of hormones and in some cases, prevents bone loss, and lowers the risk of fractures.”
However, many women experience some side effects from the medication, such as bone pain, which may be worsened by the prolonged use of progestin.
“Some women with osteoporosis are taking Depo-Provera and some women taking the medication have also developed side effects,” Dr. Susan S. Johnson, a urologist at the University of Texas Southwestern Medical Center, said in the journal “Women in Pregnancy.”
“However, these side effects are often mild and disappear in a few months.”
A study published in the journal JAMA Urology found that the use of Depo-Provera, the progestin only available in Canada, had no impact on the risk of osteoporosis or fracture in women who were taking the medication for more than a year.
“If a woman is taking Depo-Provera and she experiences osteoporosis or fracture while taking the medication, the likelihood of osteoporosis or fracture is increased,” Dr. Johnson said.
In a study published in the journal American Journal of Obstetrics and Gynecology, more than one-third of the women taking Depo-Provera developed bone loss after 12 weeks of treatment. In contrast, only half of the women taking the medication developed osteoporosis or fractures after six months of treatment.
The American Academy of Pediatrics’ (AAP) statement in support of the use of Depo-Provera in women with endometriosis said: “Our research has shown that hormonal contraception may be an effective option for some women with endometriosis who wish to remain in their natural menstrual cycle.
“Our research has found that Depo-Provera has no significant impact on bone mineral density in women who are taking hormonal contraception and have osteoporosis.”
The study involved 11,500 women in the U. S. who were taking a combined contraceptive pill. The women were randomly assigned to take a progestin-only pill or a hormonal contraception method.
Patients were given a combination of either 150 mg Depo-Provera or 150 mg Provera for three months and then followed up for a year or more. The researchers determined that the combined pill had no significant impact on the risk of bone loss.
The researchers concluded that the combined pill did not protect against osteoporosis or fracture.
AAP statement said it has studied the use of the medication for women who have developed osteoporosis or fractures after three months of treatment with the combined pill and found no significant impact on bone loss.
The AAP statement said that the researchers’ findings “showed that the use of the medication for women who are taking a combined pill and have osteoporosis or fractures does not appear to cause significant risk reduction.”
The study, published in the journal JAMA Urology, was funded by the National Institute on Aging and funded by the National Institute of Child and Adolescent Medicine, the National Institute on Aging and the National Institute of Mental Health.
Originally Published: March 15, 2024 at 3:40 AM PST
This entry was posted;[email protected]/3R5PXlI'm not sure if it's allowedtodo this,withouthaving to prove yourself to be a medical professional. It's against the law.The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser.For the best experience on our site, be sure to turn on Javascript in your browser.
Common Brand Name(s): CLOMID
SKUProvera5-MG-Oral-Tablet
Provera 5MG Oral Tablet is used in the treatment of ovulatory dysfunction (male infertility) in women. It works by increasing the number of ovaries
by increasing the number of sperm, which is the egg, making it easier for sperm to penetrate and reach the egg. This helps to improve the quality of the resulting embryo. It is also used in some menopause symptoms as an additional treatment for low blood hormone levels. This medication is not recommended for use in women who are pregnant
without talking to your doctor.
Before starting this treatment, tell your doctor if you are taking, or have recently taken, a hormone replacement therapy (HRT).
Your doctor may prescribe a progestin or another progestin to supplement your regular regular hormone therapy. Taking this medication regularly may be caused by an underactive or overstimulated immune system.
This medication may increase the number or go away in some individuals. Your doctor will check to see if this medication is right for you. If at any time you are concerned that you may have increased pressure inside your uterus, tell your doctor.
If your doctor does prescribe a progestin or a progestin containing ingredient, remember to check the ingredients in the package carefully. The ingredients may vary depending on the product.
This medication may interact with, or be used spread over a large area by, certain drugs. Discuss with your doctor how you can decrease your dosage of any medicine you are taking. You may want to take precautions if you are using a condom to protect you from pregnancy. Using latex or polyurethane condoms (such as the one provided by Harris) while taking this medication may increase the risk of getting sexually transmitted diseases (STDs).
This medication should not be used during pregnancy unless it is necessary. If you become pregnant or think you may be pregnant, tell your doctor.
Some of the side effects of this medication include the following:
If any of the above apply to you, tell your doctor or pharmacist promptly.
Discuss with your doctor.
If your doctor determines that you are not successful in continuing to take Provera, you should contact your regular doctor for diagnosis and treatment. Your doctor may need to adjust your hormonal therapy dosage.
Provera is not for women who are pregnant or have been diagnosed with low hormone levels. It works by helping the body to compensate for the estrogen hormones in the body, which can lead to decreased ovarian function and reduced fetal development. However, it does not work if the ovaries are not producing eggs.
If you are using this medication for the first time, remember that your doctor only may recommend it if you have been prescribed it. Stopping Provera from being used could result in a unwanted side effect called twins.
Common side effects of Provera may include;
How SuppliedThe medication is manufactured by Abbott and is supplied as Provera (medroxyprogesterone) 0.1 mg, 0.25 mg, 0.5 mg in 10 mg/mL suspension. Provera (medroxyprogesterone) is supplied in a 7.5 mg/mL sterile, 10 mg/mL injection. Provera (medroxyprogesterone) is then dispensed in a 10 mg/mL syringe.
Pack SizePack size: 7.5 5 mL syringes (countries of 10mg/mL
Package ConditionRegular supply of Provera (medroxyprogesterone)in 10 mg/mL syringes is VIAGRA DISMISSED as the only OTC contraceptive
Please read the enclosed leaflet carefully before use.
The enclosed leaflet
Appropriately 10 mg/mL, 0.1 mg/mL or 7.5 mg/mL sterile, 10 mg/mL syringes.
Prior to supply, each syringe should be readjust to 1.0.
To ensure proper upright, the medicine should be used carefully as advised.
Storage ConditionTo maintain the medication at room temperature, the bottle should be kept at temperature of 25 - 30 °C.
Country of origin
The product sold in the UAE is manufactured in Abbott International laboratory.
Appropriate packing of provera (medroxyprogesterone) (Otc™dosing syringePlease refer to the enclosed leaflet for specific information)
Specifications
Item number:0
Package Type
Strength
Item Code:
Package Quantity
Package Criteria:Active: Yes
Supply Price
Item Strength
KW
SKU:B02EF1ZD
Prescription Not Required
VID: 0
Vitamin D1 (medroxyprogesterone) (Otc
Please refer to the enclosed leaflet for specific information
.
To ensure proper upright, the medicine should be used carefully as suggested.
Alternate Name:Brisdelle
Description:Provera specifically designed to treat infertility in women. The medication is available in tablet and capsule form and is taken orally. It is taken either as a pill or by injection once a day. Please call for more information.
Dosage Form:Capsule, Tablet
Administration Route:Oral system
Drug Class:Medroxyprogesterone acetate
Product Form:
Severity:Inflammation
Manufacturer:Viral Pharmaceuticals, Inc.
Expiration Date: October 2020
imegestone
iStockin, 2012
Product InformationPlease call for more information
It is taken by mouth with or without food. The medication is taken by mouth as required, with or without food. Provera is available in 1 mg, 2 mg, 4 mg and 8 mg tablet doses.
Stade de France Pharmacy